ELRIG are pleased to announce that Dr Jamie Thomson, Wisconsin University, one of the world’s leading experts in stem cell biology, has been confirmed as one of the Keynote Speakers for this conference.
31 May, 2011
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals, which makes the disease more aggressive, according to research published in The Journal of Pathology.
18 May, 2011
A pioneering investigation into the treatment of cervical cancer will take place at the University of Leeds following a major advancement in the study of the disease.
17 May, 2011
Today sees the launch of Palexia® SR (tapentadol prolonged release) for the oral treatment of adults with severe chronic pain, which can only be adequately managed with opioid analgesics. Palexia® SR is the first in a new class of centrally acting analgesics called MOR-NRI, which has two mechanisms of action in one molecule; both µ-opioid receptor (MOR) agonism and noradrenaline reuptake inhibition (NRI).
16 May, 2011
A new, promising marker for diagnosing prostate cancer has been discovered by Uppsala researchers with the aid of a unique method developed at the Department of Immunology, Genetics and Pathology. The study, being published this week in the journal Proceedings of the National Academy of Sciences, PNAS, can lead to more reliable diagnoses and fewer unnecessary operations.
11 May, 2011
A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA).
05 May, 2011